Literature DB >> 12963350

Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli.

Marine E Gasparian1, Valeriy G Ostapchenko, Alexey A Schulga, Dmitry A Dolgikh, Mikhail P Kirpichnikov.   

Abstract

Enteropeptidase (synonym:enterokinase, EC 3.4.21.9) is a heterodimeric serine protease of the intestinal brush border that activates trypsinogen by highly specific cleavage of the trypsinogen activation peptide following the sequence (Asp)(4)-Lys. The DNA sequence encoding the light chain (catalytic subunit) of human enteropeptidase (GenBank Accession No. U09860) was synthesized from 26 oligonucleotides by polymerase chain reaction and cloned into plasmid pET-32a downstream to the gene of fusion partner thioredoxin immediately after the DNA sequence encoding enteropeptidase recognition site. The fusion protein thioredoxin/human enteropeptidase light chain was expressed in Escherichia coli BL21(DE3) strain in both soluble and insoluble forms. The soluble recombinant fusion protein failed to undergo autocatalytic cleavage and activation; however, autocatalytic cleavage and activation of recombinant human enteropeptidase light chain (L-HEP) were achieved by solubilization and renaturation of the fusion protein from inclusion bodies and the active L-HEP was purified on agarose-linked soybean trypsin inhibitor. The purified L-HEP cleaved the synthetic peptide substrate Gly-Asp-Asp-Asp-Asp-Lys-beta-naphthylamide with kinetic parameters K(m)=0.16 mM and k(cat)=115 s(-1) and small ester Z-Lys-SBzl with K(m)=140 microM, k(cat)=133 s(-1). L-HEP associated with soybean trypsin inhibitor slowly and small ester Z-Lys-SBzl cleavage was inhibited with K(i)(*)=2.3 nM. L-HEP digested thioredoxin/human epidermal growth factor fusion protein five times faster than equal activity units of bovine recombinant light chain (EKMax, Invitrogen) at the same conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963350     DOI: 10.1016/s1046-5928(03)00159-1

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

1.  Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.

Authors:  Xufan Tian; Nigora S Isamiddinova; Raymond J Peroutka; Seth J Goldenberg; Michael R Mattern; Benjamin Nicholson; Craig Leach
Journal:  Assay Drug Dev Technol       Date:  2010-12-06       Impact factor: 1.738

2.  Structural similarity between defense peptide from wheat and scorpion neurotoxin permits rational functional design.

Authors:  Antonina A Berkut; Dinara R Usmanova; Steve Peigneur; Peter B Oparin; Konstantin S Mineev; Tatyana I Odintsova; Jan Tytgat; Alexander S Arseniev; Eugene V Grishin; Alexander A Vassilevski
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

3.  Protein surface topography as a tool to enhance the selective activity of a potassium channel blocker.

Authors:  Antonina A Berkut; Anton O Chugunov; Konstantin S Mineev; Steve Peigneur; Valentin M Tabakmakher; Nikolay A Krylov; Peter B Oparin; Alyona F Lihonosova; Ekaterina V Novikova; Alexander S Arseniev; Eugene V Grishin; Jan Tytgat; Roman G Efremov; Alexander A Vassilevski
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

4.  New strategy for high-level expression and purification of biologically active monomeric TGF-β1/C77S in Escherichia coli.

Authors:  Yana V Kim; Marine E Gasparian; Eduard V Bocharov; Rita V Chertkova; Elena N Tkach; Dmitry A Dolgikh; Mikhail P Kirpichnikov
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

5.  Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity.

Authors:  Zenichi Ikeda; Keiko Kakegawa; Fumiaki Kikuchi; Sachiko Itono; Hideyuki Oki; Hiroaki Yashiro; Hideyuki Hiyoshi; Kazue Tsuchimori; Kenichi Hamagami; Masanori Watanabe; Masako Sasaki; Youko Ishihara; Kimio Tohyama; Tomoyuki Kitazaki; Tsuyoshi Maekawa; Minoru Sasaki
Journal:  J Med Chem       Date:  2022-06-10       Impact factor: 8.039

6.  Directed evolution for soluble and active periplasmic expression of bovine enterokinase in Escherichia coli.

Authors:  Weiluo Lee; Subhas Pradhan; Cheng Zhang; Niccolo A E Venanzi; Weina Li; Stephen Goldrick; Paul A Dalby
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

7.  Recombinant Kv channels at the membrane of Escherichia coli bind specifically agitoxin2.

Authors:  Oksana V Nekrasova; Anastasia A Ignatova; Anna I Nazarova; Alexey V Feofanov; Yuliya V Korolkova; Elena F Boldyreva; Anna I Tagvei; Eugene V Grishin; Alexander S Arseniev; Mikhail P Kirpichnikov
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-23       Impact factor: 4.147

8.  Bacterial Synthesis and Purification of Normal and Mutant Forms of Human FGFR3 Transmembrane Segment.

Authors:  S A Goncharuk; M V Goncharuk; M L Mayzel; D M Lesovoy; V V Chupin; E V Bocharov; A S Arseniev; M P Kirpichnikov
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

Review 9.  An overview of enzymatic reagents for the removal of affinity tags.

Authors:  David S Waugh
Journal:  Protein Expr Purif       Date:  2011-08-19       Impact factor: 1.650

10.  Potassium channel blocker crafted by α-hairpinin scaffold engineering.

Authors:  Valentin M Tabakmakher; Andrei M Gigolaev; Steve Peigneur; Nikolay A Krylov; Jan Tytgat; Anton O Chugunov; Alexander A Vassilevski; Roman G Efremov
Journal:  Biophys J       Date:  2021-04-29       Impact factor: 3.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.